Current Report Filing (8-k)

Date : 11/09/2018 @ 8:19PM
Source : Edgar (US Regulatory)
Stock : InventaBioTech Inc. (INVB)
Quote : 0.0255  0.0 (0.00%) @ 1:23PM

Current Report Filing (8-k)

 


 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

 of the Securities Exchange Act of 1934

 

Date of the Report (Date of earliest event reported):  November 5, 2018

 

WESTMOUNTAIN COMPANY

(Exact Name if Business Issuer as specified in its Charter)

 

Colorado   000-53030   26-1315305

(State or other Jurisdiction

of Incorporation)

 

(Commission File

Number)

 

(IRS Employer

Identification Number)

 

     
  3463 Magic Drive, Suite 120  
  San Antonio, TX 78229  
   (Address of principal executive offices, including zip code)  

 

(210) 767-2727

(Registrant's telephone number including area code)

 

(Former Name or Former Address, if Changed Since the Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

     
 

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On November 5, 2018, Henry Bourg, Chief Financial Officer (“CFO”) of WestMountain Company (the “Company”) informed the Company that he was resigning as CFO effective immediately.

 

On November 5, 2018, the Company appointed Brian Zucker, CPA, as CFO, effective immediately. The CFO serves as the Company’s principal financial officer and principal accounting offer.

 

Mr. Zucker, 57, has been a principal of CFO Financial Partners, LLC (“CFO Financial”) since 2011. CFO Financial provides a broad range of accounting, tax and regulatory related services to publicly traded companies, hedge funds, and high net worth individuals, and is a practice unit of RRBB Accountants and Advisors, a 50+ year old public accounting firm. He has over thirty years of experience as a CPA specializing in the securities industry. Mr. Zucker started his career as a Senior Consultant at Deloitte Haskins and Sells and later Price Waterhouse. He has previously served as the President and Chairman of Atlantis Business Development Corp., CFO of Natcore Solar Technology, Inc., and as a Managing Director of American Frontier Financial Corp. Mr. Zucker has a BS in Business (Accounting) from Pace University.

 

Family Relationships

 

There are no family relationships between Mr. Zucker and any other employees or members of the board of directors of the Company.

 

Related Party Transactions

 

There are no related party transactions with regard to Mr. Zucker reportable under Item 404(a) of Regulation S-K.

 

Material Plans, Contracts, or Arrangements

 

In connection with Mr. Zucker’s appointment, the Company will pay $4,000 per month to CFO Financial. The Company will issue shares of restricted common stock to CFO Financial at a later date. 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

November 9, 2018


 

WESTMOUNTAIN COMPANY

 

 

By: /s/  James R. Garvin  

James R. Garvin, Chief Executive Officer

 (Principal Executive Officer)

 

 

     
 

InventaBioTech Inc. (USOTC:INVB)
Historical Stock Chart

1 Year : From Jul 2018 to Jul 2019

Click Here for more InventaBioTech Inc. Charts.

InventaBioTech Inc. (USOTC:INVB)
Intraday Stock Chart

Today : Sunday 21 July 2019

Click Here for more InventaBioTech Inc. Charts.

Latest INVB Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.